Aevice Health
Also, fellow Korean medical AI companies have obtained regulatory approvals across global markets.
Also, Aevice Health from Singapore has obtained new investment for its global expansion.
It is also solidifying its presence in the United States market through Cedars-Sinai's backing.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
Also, Seegene will be leveraging Microsoft's AI to advance the development of syndromic quantitative PCR diagnostic tests globally.
It recently obtained a 510(k) clearance from the US and funding for its expansion in Southeast Asia.
Also, Olympus has come up with the third-generation Visera Elite surgical visualisation platform for endoscopic procedures.
The NUHS will facilitate the study on AeviceMD's use in detecting wheezing among paediatric patients with breathing difficulties.
The Singaporean firm has also partnered with Japan's Toho Holdings to develop and market its device.